Mental health has quietly become the backbone of American telehealth, and the numbers behind this shift are striking. Remote therapy is no longer a supplemental option at the edges of the healthcare system. It is now the dominant reason Americans use digital health platforms, reshaping how investors, founders, and policymakers view the industry.
Throughout 2024 and into early 2026, mental health conditions consistently held the top diagnostic category in telehealth nationally and across every US Census region. This structural consistency signals more than a trend; it points to a transformation in how mental healthcare is delivered at scale.
What follows is an analysis of the forces driving that transformation: the utilization data that confirms the shift, the regional patterns that reveal where the market is maturing unevenly, and the competitive dynamics among leading startups that will determine which models survive the next consolidation phase.

The Utilization Data Behind Remote Therapy’s Rise
The evidence of remote therapy’s shift from the periphery to the center of American healthcare is not anecdotal. FAIR Health, a nonprofit managing one of the largest repositories of private health insurance claims in the U.S., has tracked this shift with monthly data throughout 2024.
According to the FAIR Health’s Monthly Telehealth Regional Tracker, mental health conditions accounted for roughly 66 to 67 percent of all telehealth claim lines nationally throughout early 2024. By the first quarter of 2026, approximately 52 percent of all patients with a telehealth claim received a mental health diagnosis, a figure that held across every age group, including children under ten.
Overall telehealth utilization also expanded steadily. Nationally, telehealth’s share of medical claim lines rose by more than six percent between July and December 2024 alone. That upward trajectory continued into 2026, with telehealth utilization increasing across all four US Census regions from Q4 2025 to Q1 2026, with the Midwest leading with a 12 percent relative gain.
What the Top Diagnoses Actually Reveal
The top five mental health diagnoses driving virtual care usage showed remarkable consistency across regions and time periods. Generalized anxiety disorder held the top position nationally and in every region throughout 2024. Major depressive disorder, adjustment disorders, ADHD, and post-traumatic stress disorder rounded out the list, a pattern that repeated month after month.
These are conditions where the therapeutic relationship (the conversation, consistency, and accessibility) determines outcomes, which explains why mental health dominates telehealth in a way that cardiovascular care or orthopedics simply cannot replicate.
Furthermore, the cost data adds another dimension: in February 2024, a 45-minute psychotherapy session delivered via telehealth carried a higher median allowed amount than the same session in an office setting, both nationally and in every region.
In the Midwest, for instance, telehealth cost $93 versus $82 in-office. This premium reflects reimbursement dynamics and the value payers assign to virtual mental health access.
Regional Patterns: Uneven Maturity, Unequal Access
The national numbers tell one story. The regional breakdown tells a more complex one, and strategically, the regional divergence matters just as much as the aggregate growth.
According to FAIR Health’s December 2024 tracker data, telehealth utilization increased nationally and in every region except the West, where it declined slightly. The South and Midwest showed the strongest growth momentum in the final months of 2024, while the Northeast demonstrated consistent but moderate expansion.
Regional diagnostic differences reveal even sharper contrasts, with the Midwest’s top five telehealth diagnostic categories included both substance use disorders and sleep disorders, categories absent from the national top five.
The West, notably, included COVID-19, diabetes mellitus, and abnormal blood-pressure readings in its regional top five, conditions not appearing prominently in any other region’s rankings during the same period.
Rural Growth as a Signal of Structural Change
Perhaps the most strategically significant regional signal in the recent data involves the rural-urban divide. Rural patients with telehealth claims grew at a faster rate than urban patients from Q4 2025 to Q1 2026 (roughly 7.8 percent versus 6.2 percent), even though rural patients remain less likely to use telehealth overall.
That faster rural growth rate signals that remote therapy is penetrating communities that have historically lacked mental health providers. For startups and investors, this represents both an untapped market and a policy-relevant use case that could accelerate favorable regulatory treatment.
| Region | Telehealth Utilization Trend (H2 2024) | Notable Diagnostic Differences |
|---|---|---|
| National | +6.13% (Jul–Dec 2024) | Mental health #1; hypertension in top five |
| Midwest | Strong growth; +5.6% in December | Substance use and sleep disorders unique to region |
| Northeast | Moderate growth; +3.1% in December | Substance use disorders in top five; highest anxiety share |
| South | Steady growth; +4.7% in December | Only region with hypertension consistently ranked |
| West | Slight decline in December (-0.9%) | COVID-19, diabetes, abnormal BP readings unique to region |
These regional divergences suggest that the remote therapy market is not maturing uniformly. Instead, different parts of the country are developing distinct demand profiles, a reality any platform attempting a national rollout must consider in its clinical design and payer strategy.
The Competitive Landscape: Who Is Actually Winning?
The demand validation is clear. What remains contested is which companies will convert that demand into durable market positions. The competitive field among online therapy startups has shifted considerably, and the distinctions between the leading models reveal the strategic chokepoints every entrant must navigate.
Revenue Proof Versus System Scale
Grow Therapy currently holds the strongest verified revenue position among private online therapy companies, with publicly confirmed 2024 revenue exceeding $617 million and a compound annual growth rate that placed it first in the Financial Times ranking of the Americas’ fastest-growing companies.
The platform facilitated seven million visits during 2025 alone and has reached over two million patients. These numbers represent completed activity, not forward-looking projections.
Spring Health, after its acquisition of Alma, has built a broader distribution architecture. The combined entity gives over 170 million people access through employer and health plan channels. However, the projected $1 billion in combined annual revenue still depends on integration execution, making Spring a company with broader potential reach but more conditional near-term performance.
Meanwhile, Headway operates the largest provider network in the space, with over 80,000 therapists and psychiatric providers accepting insurance through its platform. Yet its patient volume and revenue disclosures remain thin relative to its supply-side infrastructure.
Rula presents a different profile with an average insured session cost of $15, a median patient wait of one day, and a clinical data set from over ten million sessions, positioning it as the most credible access-focused challenger.
Clinical Evidence as the Next Differentiator
Lyra Health occupies a distinct position. Instead of competing on provider volume or revenue growth, Lyra has built the deepest research foundation in the space, with over 20 peer-reviewed studies, one-year follow-up outcome data, and evidence linking its platform to lower healthcare claims. As the market matures, clinical credibility at scale may prove more durable than any single growth metric.
The broader pattern is clear: the era when raising capital and signing up providers was sufficient to establish market position has ended. Payers, employers, and health systems evaluating virtual mental health partnerships now ask harder questions about outcomes, cost-per-session, provider quality, and wait times.
What the Investment Climate Signals
The capital flowing into this space reflects both the validated opportunity and increasing investor selectivity. Digital health startups raised over $10 billion across nearly 500 deals in 2024, with mental health consistently ranked as a top therapeutic area by funding volume.
In H1 2024 alone, mental health attracted over $1.3 billion in investment, a 63 percent year-over-year increase that outpaced oncology, historically the leading category for digital health investment.
Nevertheless, the composition of that investment is shifting. Early-stage speculative rounds are giving way to larger commitments to companies that can demonstrate payer integration, measurable outcomes, and sustainable unit economics.
The startups positioned to capture the next wave of capital are those that have already solved the access problem and are now building the evidence infrastructure that enterprise buyers require.
Additionally, the regulatory environment remains a consequential variable. Medicare telehealth flexibilities introduced during the COVID-19 pandemic, which removed geographic restrictions and allowed mental health services to be delivered from patients’ homes, have been repeatedly extended but not yet made permanent.
The accumulating utilization data from FAIR Health and similar sources provide the strongest argument for permanence, and recent Q1 2026 findings confirming mental health as the top telehealth diagnosis across every age group add significant weight to that case.
Strategic Implications for Founders and Investors
Several considerations separate the platforms likely to consolidate market share from those that will plateau or fail. They are worth naming explicitly:
- Secure payer integration early. Platforms operating on out-of-pocket payments face a ceiling, while insurance coverage expands the addressable market and average patient lifetime value.
- Build outcomes data deliberately. Clinical evidence, not provider network size, is becoming the primary differentiator for enterprise buyers.
- Map regional demand carefully. Significant diagnostic and utilization differences between regions require tailored strategies, not uniform national rollouts.
- Invest in rural access infrastructure. The fastest-growing patient segment is in underserved rural areas. Platforms that solve this access problem can earn market share and regulatory goodwill.
- Track provider network quality, not just size. Utilization efficiency is a better proxy for platform health than raw provider numbers. Completed appointment volume, for example, matters more than the absolute size of a provider network.
You May Also Like
- 👉 Corporate Wellness: A Booming B2B Startup Idea in the US
- 👉 Remote Work Security: The Future for Modern US Businesses Now
The Path Forward
Remote therapy has earned its position as the defining application of telehealth in the United States, and that position is unlikely to erode. The depth of unmet need, the structural advantages of virtual delivery for behavioral health, and the increasingly favorable policy trajectory all point toward continued expansion.
For those inside this market, whether as builders, backers, or buyers, the relevant frame is no longer adoption risk, but execution risk.
Additionally, the platforms that will shape the next decade of virtual mental healthcare are the ones already solving the harder problems: integrating with payers, measuring outcomes rigorously, and reaching the patients that traditional systems have left most underserved.
In a market this consequential, the distance between leading and following tends to compound faster than most observers expect.
Watch this video to learn more about remote therapy and how online mental health care works.
Frequently Asked Questions
What are the benefits of remote therapy for mental health treatment?
How does telehealth impact cost for mental healthcare?
What types of mental health issues are most commonly treated via telehealth?
Is telehealth equally accessible across different regions in the US?
What role do regulatory changes play in the telehealth landscape?






